Trial Information

Summary: Research study of an investigational medication for Primary Insomnia

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Outpatient Trial of XXXX in Adults with Primary Insomnia

Length of study: Up to 8 weeks
Number of office visits: 8 for most subjects

At no cost, qualified participants receive study medication and study related services. In addition there is compensation up to $600.00 for time and travel.

Patient Inclusion Criteria
This study is only available to persons who:

• Can fluently read and speak English
• Are 18 to 64 years old
• Are without serious health problems
• Are not addicted to drugs or alcohol
• Are not currently taking sedating medications or supplements

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: August 6, 2008 at 2:59:54 PM